spartacus-biomed.fr évaluation et analyse
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Crawl-delay : 60 Disallow : /*calendar* Disallow : /*guestbook* | ||
Meta Tags
| Title | HOME - |
| Description | Services et produits de haute qualité, toutes les informations sur les options d’achat et sur la |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 185.98.131.157 |
| Location | - |
Sites Web connexes
| Site | Rank |
| sparagus.be | 4,670,891 |
Plus à explorer
spartacus-biomed.fr Évaluation
|
Euro€486,715
Dernière mise à jour: 2022-10-03 09:37:22
spartacus-biomed.fr a un classement mondial Semrush de 21,746,414. spartacus-biomed.fr a une valeur estimée à € 486,715, sur la base de ses revenus publicitaires estimés. spartacus-biomed.fr reçoit environ 56,160 visiteurs uniques chaque jour. Son serveur Web est situé au -, avec l'adresse IP 185.98.131.157.Selon SiteAdvisor, spartacus-biomed.fr est sûr à visiter. |
Trafic & Estimations de la valeur
| Valeur d'achat/vente | Euro€486,715 |
| Revenus publicitaires quotidiens | Euro€450 |
| Revenus publicitaires mensuels | Euro€13,479 |
| Revenus publicitaires annuels | Euro€161,740 |
| Visiteurs uniques quotidiens | 3,744 |
| Remarque: Toutes les valeurs de trafic et de revenus sont des estimations. | |
DNS Records
| Host | Type | TTL | Data |
| spartacus-biomed.fr. | A | 21600 | IP: 185.98.131.157 |
| spartacus-biomed.fr. | NS | 21600 | NS Record: ns1.lws-hosting.net. |
| spartacus-biomed.fr. | NS | 21600 | NS Record: ns2.lws-hosting.net. |
| spartacus-biomed.fr. | MX | 21600 | MX Record: 10 mail.spartacus-biomed.fr. |
HtmlToTextCheckTime:2022-10-03 09:37:22
| HOME COVID - 19 Antigen Rapid Test LFA COVID -19 IgG & IgM Rapid Test Device SARS-CoV-2 Saliva Rapid Test FILDARIA Contact Us R&D EVENTS ISO13485 Certificate Traceability sheet MEETING AND EXIBITIONS © 2020. Spartacus-Biomed Click to learn more Click to learn more Spartacus-Biomed a R&D Company The world global market for in vitro diagnostic tests is predicted to reach a compound annual growth rate (CAGR) of 12 % over the next five-year period. Spartacus-Biomed business model is focused on biomarkers which are estimated to peak annual turnovers of up to 800 M€ in Europe. Indeed, the biomarkers are being increasingly used to aid for diagnosis, to a much lesser extend for prognosis and to identify sub-populations with differing benefit-risk ratios. Spartacus-Biomed is providing novel Biomarkers that will equip physicians with tools to improve the early diagnosis, to identify patients at risk of developing diseases, and to characterize patient subsets with a greater likelihood of |
HTTP Headers
HTTP/1.1 200 OK Server: nginx Date: Fri, 21 Jan 2022 11:33:53 GMT Content-Type: text/html; charset=utf-8 Connection: keep-alive X-Powered-By: PHP/7.3.33 Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate Pragma: no-cache Set-Cookie: PHPSESSID=b9f331dcb914436ab1612149c5b91812; path=/ Vary: Host |